Skip to Content

NATCO 30 (Lansoprazole Delayed-Release 30 mg)

Pill with imprint NATCO 30 is Blue & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Lansoprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; aspiration pneumonia (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 30

Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30

Lansoprazole Delayed-Release

Imprint:
NATCO 30
Strength:
30 mg
Color:
Blue & Pink
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0772

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide